We are live on
!
Find out more
SC
Scholtz & Company Portfolio holdings
AUM
$195M
1-Year Est. Return
12.04%
This Fund
S&P 500
This Quarter
Est. Return
+9.87%
1 Year Est. Return
+12.04%
3 Year Est. Return
+82.55%
5 Year Est. Return
+94.25%
10 Year Est. Return
+790.35%
AUM
$292M
AUM Growth
+$29.2M
(+11%)
Cap. Flow
+$3.98M
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
45.55%
Holding
80
New
12
Increased
47
Reduced
11
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMEO
Vimeo
VMEO
|
+$4.15M |
| 2 |
Generac Holdings
GNRC
|
+$3.06M |
| 3 |
Netflix
NFLX
|
+$2.58M |
| 4 |
IAA
IAA, Inc. Common Stock
IAA
|
+$2.24M |
| 5 |
Air Products & Chemicals
APD
|
+$2.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$7.29M |
| 2 |
The Joint Corp
JYNT
|
+$5.12M |
| 3 |
Progyny
PGNY
|
+$4.32M |
| 4 |
PPLI
People Inc
PPLI
|
+$3.15M |
| 5 |
Match Group
MTCH
|
+$1.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.51% |
| 2 | Consumer Discretionary | 22.41% |
| 3 | Communication Services | 12.75% |
| 4 | Healthcare | 12.74% |
| 5 | Financials | 9.68% |
Similar funds
HAS
MHFA
TF
RAM
ICMARC
CPRPA
WAL
CPI
Scholtz & Company's Q2 2021 Portfolio in Review
As of Q2 2021, Scholtz & Company held 80 positions worth $292M, up 11% from $263M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Scholtz & Company's Q2 2021 filing shows 12 new, 47 increased, 11 reduced and 8 closed positions. Its largest new stake was Vimeo: 90,179 shares worth $4.42M. The largest sale was Teladoc Health, an estimated $7.29M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Scholtz & Company's largest Q2 2021 buy was Vimeo: 90,179 shares worth $4.42M.
- Scholtz & Company added most to Netflix in Q2 2021, an estimated $2.58M increase.
- Scholtz & Company's biggest Q2 2021 reduction was The Joint Corp, cutting an estimated $5.12M.
- Scholtz & Company fully exited Teladoc Health in Q2 2021, selling an estimated $7.29M.
- Scholtz & Company's ten largest holdings make up 46% of its $292M portfolio in Q2 2021.
- Scholtz & Company opened 12 new positions and closed 8 in Q2 2021.
- Scholtz & Company's portfolio value rose 11% quarter-over-quarter to $292M.
Based on Scholtz & Company's 13F filing for Q2 2021, filed 9 Aug 2021.